D-0745-2022 Class III Terminated

Recalled by The Ritedose Corporation — Columbia, SC

FDA drug recall D-0745-2022 was initiated by The Ritedose Corporation on Apr 1, 2022 and is designated Class III. Reason for recall: Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL. The recall status is terminated (terminated Dec 2, 2022). Affected quantity: 3795 syringes.

Recall details

Product Type
Drugs
Report Date
Apr 13, 2022
Initiation Date
Apr 1, 2022
Termination Date
Dec 2, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3795 syringes

Product description

23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx Only, RITEDOSE, 503B Outsourcing Facility, A Division of the RITEDOSE Corporation, 1 Technology Circle, Columbia, SC 29203, 1-866-994-4670, NDC: 65302-509-30, barcode N (01) 003 65302 50930 0

Reason for recall

Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

Distribution pattern

Nationwide in the USA

Code information

Lots: 210137-01 BUD: 05/25/2022; 220026-01 BUD: 8/12/2022; 220050-01 BUD: 08/22/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0745-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0745-2022. Report a data issue: hello@regdatalab.com.